Join Nishtha Jain from Takeda Pharmaceuticals as she explores how AI boosts efficiencies in drug development. Delve into AI's impact on drug discovery, compliance workflows, and data quality in the life sciences sector. Learn about driving AI implementation with executive buy-in and its transformative potential in the industry post-COVID-19.
Read more
AI Summary
AI Chapters
Episode notes
auto_awesome
Podcast summary created with Snipd AI
Quick takeaways
AI accelerates drug discovery, reducing time and costs.
AI enhances clinical trials, improving success rates and patient outcomes.
Deep dives
Efficiencies AI Can Drive in Drug Development
AI holds incredible potential for healthcare by accelerating drug discovery and improving patient outcomes, reducing the time and cost involved in drug development. The pharmaceutical value chain, consisting of drug discovery, clinical research, and FDA review, can take many years and significant costs. AI technologies have shown in real-world examples, such as the accelerated COVID-19 vaccine development, how they can streamline processes, reduce timelines, and improve data quality.
AI Use Cases in Drug Discovery Space
AI is revolutionizing the life sciences industry by enhancing target identification, drug design, clinical trials acceleration, and drug metabolism studies. AI-discovered molecules have shown success rates in clinical trials higher than historical averages, indicating AI's potential to improve drug development success rates. Furthermore, generative AI capabilities promise to accelerate drug discovery processes, enhance patient outcomes, and automate time-consuming tasks, ultimately benefiting clinicians and patients.
Driving AI Adoption in Life Sciences
To drive successful AI adoption, organizations must develop a clear AI strategy aligned with business goals, emphasize embedding AI in organizational processes, and communicate transformation stories to inspire excitement and awareness. Leaders should focus on problem-solving before selecting solutions and prioritize attracting and upskilling talent for AI-related roles. Compliance with data quality, privacy, regulatory, and cybersecurity standards is crucial for successful AI implementation, requiring robust policies and collaboration among data scientists, leaders, and regulators.
Today’s guest is Nishtha Jain, Head of Innovation and Digital Technology at Takeda Pharmaceuticals. Her role expands across Global R&D Quality in driving digital and data initiatives from concept to execution, leveraging emerging technologies and design principles. She joins us on the podcast today to talk about the efficiencies that AI can drive in the drug development space and how that benefits the entire value chain in life sciences. If you’ve enjoyed or benefited from some of the insights of this episode, consider leaving us a five-star review on Apple Podcasts, and let us know what you learned, found helpful, or liked most about this show!
Get the Snipd podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered podcast player
Listen to all your favourite podcasts with AI-powered features
Discover highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share & Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered podcast player
Listen to all your favourite podcasts with AI-powered features
Discover highlights
Listen to the best highlights from the podcasts you love and dive into the full episode